About FSD Pharma
FSD Pharma is a publicly listed company based in Cobourg (Canada) founded in 2018 by Anthony Durkacz and Zeeshan Saeed. Cannabis company engaged in cultivation, processing, and manufacturing related activities. FSD Pharma has completed 3 acquisitions, including Lucid Psycheceuticals, Prismic Pharmaceuticals and Therapix Biosciences. Its chief executive, as recorded, is Raza Bokhari. FSD Pharma offers products and services including LUCID-MS and UNBUZZD. Its focus areas include Life Sciences, Cannabis CRO Services, CRO and Clinical Trial Supply. Its competitors include Terranueva and BIOME.
Company details
FSD Pharma, established in 2018 and currently in Public stage, focuses on life sciences, cannabis cro services, cro, and clinical trial supply. Cannabis company engaged in cultivation, processing, and manufacturing related activities. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Cobourg, Canada
- Founders Anthony Durkacz, Zeeshan Saeed
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website fsdpharma.com
- Social LinkedIn X Facebook YouTube
- Investments & AcquisitionsLucid Psycheceuticals
& 2 more
Products & Services of FSD Pharma
FSD Pharma offers a comprehensive portfolio of products and services, including LUCID-MS and UNBUZZD.
Prevents and reverses myelin degradation for Multiple Sclerosis treatment.
Supports rapid alcohol detoxification and improves post-drinking wellness.
Apps and channels of FSD Pharma
its YouTube channel Quantum BioPharma has 92 subscribers and 30 videos.
Videos from FSD Pharma
The most watched videos on FSD Pharma's YouTube channel, Quantum BioPharma (92 subscribers). Click a video to play it here.
More on Quantum BioPharma.
Funding Insights of FSD Pharma
- Total Rounds 4
- First Round $3.46M
(Sep 2019)
All 4 funding rounds of FSD Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | Post-IPO | – | – | – | |
| Jun 2020 | $7.5M | Post-IPO | – | – | – |
| Nov 2019 | $10,040 | Post-IPO | – | – | – |
| Sep 2019 | $3.46M | Post-IPO | – | – | – |
People of FSD Pharma
28 people are tracked at FSD Pharma (11 in leadership, 16 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Anthony Durkacz | Co-Founder | Leadership |
Zeeshan Saeed | Co-Founder | Leadership |
Raza Bokhari | CEO | Leadership |
Sara May | President, FV Pharma Inc. | Leadership |
Edward J. Brennan | President, FSD Pharma BioSciences Division | Leadership |
Sandy Huard | Head of Investor Relations | Leadership |
Patrick Oyanango | Director, Operations, US | Leadership |
Sandra Lottes | VP & Head of Clinical Research, FSD BioSciences Division | Leadership |
Sima Salahshor | Associate Director, Scientific & Clinical Affairs | Leadership |
Joanne Speed | Senior Director, Drug Development | Leadership |
Shahzad Shah | COO FV Pharma Inc. | Leadership |
Mallory Loflin | Scientific Advisor | Board & advisors |
David Urban | Director | Board & advisors |
Gerry David | Advisor | Board & advisors |
Eric Hoskins | Director | Board & advisors |
Kevin Harrington | Advisor | Board & advisors |
Eleanor Fish | Research & Clinical Advisory Board Member | Board & advisors |
Kwok Chow | Regulatory Advisory Board Member | Board & advisors |
Peter K. Stys | Expert Advisory Committee Member | Board & advisors |
Nathan Coyle | Director | Board & advisors |
8 more people are available in the full profile.
Complete people profiles for FSD Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FSD Pharma
FSD Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Lucid Psycheceuticals, Prismic Pharmaceuticals and Therapix Biosciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drugs for mental health disorders are manufactured and developed. | lucidpsycheceuticals.com | Toronto, Canada | 2020 | Sep 2021 | $8.82M | |
Medical drugs for the treatment of inflammation and oxidative stress | prismicpharma.com | Worcester, United States | 2011 | Apr 2019 | $17.5M | |
Cannabinoid-based therapies for central nervous system disorders are developed. | therapixbio.com | Givatayim, Israel | 2014 | Oct 2018 | $48M |
Complete acquisition details for FSD Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of FSD Pharma
7 dated milestones of FSD Pharma across 5 years, from founding to its latest funding, stage changes and deals.
- Founded FSD Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Therapix Biosciences.
- Acquisition Acquires Prismic Pharmaceuticals.
- Funding First funding round of $3.5M.
- Acquisition Acquires Lucid Psycheceuticals.
- Funding Latest funding round, Post-IPO,.
Competitors of FSD Pharma
FSD Pharma has 2 listed competitors in our database. They include Terranueva and BIOME.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| terranueva.ca | 2007 | L Assomption, Canada | Production of cannabis products is handled by Terranueva in Canada. | |||
| biomegrow.com | 2013 | Toronto, Canada | Online platform for slot gaming with stable servers and daily jackpots |
Detailed competitors of FSD Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cannabis Health Tech Ecosystem
2 companies that operate in the same segment as FSD Pharma (Cannabis Health Tech Ecosystem) in Canada, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | USD 204.24 M | 960 | ||
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | USD 186.16 M | 898 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fsd Pharma
Complete news archive for FSD Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FSD Pharma
FSD Pharma was founded in 2018 and raised its 1st funding round 1 year after it was founded.
FSD Pharma is headquartered in Cobourg, Canada. It is registered at Cobourg, Ontario, Canada.
Raza Bokhari is the CEO of FSD Pharma, as recorded in our data.
FSD Pharma, established in 2018 and currently in Public stage, focuses on life sciences, cannabis cro services, cro, and clinical trial supply. Cannabis company engaged in cultivation, processing, and manufacturing related activities. Adapting to market demands with innovation and client-focused strategies.
FSD Pharma's top competitors include Terranueva and BIOME.
FSD Pharma offers LUCID-MS and UNBUZZD.
FSD Pharma has made 3 acquisitions, including Lucid Psycheceuticals, Prismic Pharmaceuticals, and Therapix Biosciences.